Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Titration pathway for patients with a confirmed ADHD diagnosis. Includes an initial review (45–60 mins) and up to 3 follow-ups over 8–10 weeks, with side-effect monitoring, dose adjustment and shared care support with your GP. Additional reviews beyond the pathway are charged at the standard rate.
Titration pathway for patients with a confirmed ADHD diagnosis. Includes an initial review (45–60 mins) and up to 3 follow-ups over 8–10 weeks, with side-effect monitoring, dose adjustment and shared care support with your GP. Additional reviews beyond the pathway are charged at the standard rate.